Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03686150 · ClinicalTrials.gov registry record · NA

Vitamin D Oral Replacement in Asthma

A NA study of Asthma and Vitamin D Deficiency, sponsored by IDeA States Pediatric Clinical Trials Network.

Completed
Registry status
NA
Development phase
112
Enrollment target
15
Study locations

NCT03686150 is a NA study of Asthma and Vitamin D Deficiency that has completed, run by IDeA States Pediatric Clinical Trials Network. The registered enrollment target is 112 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (93% lower). The trial reports 15 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03686150, a NA study of Asthma and Vitamin D Deficiency, has completed, sponsored by IDeA States Pediatric Clinical Trials Network.

COMPLETED
Registry status
NA
Development phase
112 participants
Enrollment target
15
Study locations

Study Summary

The overall objective of the study is to determine the pharmacokinetics of Vitamin D supplementation in children who have asthma and are overweight or obese.

Interventions

  • DIETARY_SUPPLEMENT Vitamin D3 oral regimen

Study Locations (15)

Arkansas

  • Arkansas Children's Hospital - Little Rock

Delaware

  • Nemours/Alfred I duPont Hospital for Children - Wilmington

Hawaii

  • Kapiolani Medical Center for Women and Children - Honolulu

Kentucky

  • University of Louisville - Louisville

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge

Mississippi

  • University of Mississippi Medical Center - Jackson

Missouri

  • Children's Mercy Hospital - Kansas City

Montana

  • Community Medical Center - Missoula

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2019-01-30
Est. Completion 2021-09-30
Phase NA

What the Registry Record Tells You About NCT03686150

The ClinicalTrials.gov registry entry for NCT03686150 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (93% lower). The listed sponsor is IDeA States Pediatric Clinical Trials Network, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Vitamin D3 oral regimen is the first listed.

NCT03686150 reports 15 study locations spanning 15 distinct geographic areas - top geographies include Arkansas, Delaware, Hawaii.

Frequently Asked Questions

What is clinical trial NCT03686150 about?

NCT03686150 is a clinical study titled "Vitamin D Oral Replacement in Asthma". The overall objective of the study is to determine the pharmacokinetics of Vitamin D supplementation in children who have asthma and are overweight or obese.

What is the current status of trial NCT03686150?

This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2019-01-30. Estimated completion is 2021-09-30.

What conditions does trial NCT03686150 study?

This clinical trial studies the following conditions: Asthma, Vitamin D Deficiency, Pediatric Obesity.

What interventions are being tested in trial NCT03686150?

The interventions under investigation include: Vitamin D3 oral regimen (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03686150?

This trial is sponsored by IDeA States Pediatric Clinical Trials Network, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03686150 being conducted?

This trial has 15 study locations across Arkansas, Delaware, Hawaii, Kentucky, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.